Zoonotic Influenza Surveillance in Belgium
NCT05827601 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2023-09-08
Summary
The project aims at implementing a more pro-active surveillance of potential transmission of influenza viruses to humans (zoonotic transmission). Clinical surveillance of influenza in humans and avian species is well organized and has been operating for decades, but currently there is no pro-active systematic surveillance of potential transmission of animal (avian or swine) influenza viruses to humans, only follow-up of people showing clinical symptoms. People working with potentially infected animals have the highest risk. Moreover, they can represent the first steps in a pandemic: if the virus adapts to humans, infected workers could potentially spread the virus to other people.
Currently, highly pathogenic clade2.3.4.4b H5 avian influenza viruses are continuously circulating in wild birds in Belgium and the number of introduction in poultry farms has raised, increasing the contact opportunities with high viral concentrations. Several reports of suspected human infection have been made by different countries. In addition, the virus was detected in sick non-human mammals. The large circulation in wild birds thus represents an increase risk of spill-over to mammalian species, including humans, (by contact directly with wild birds, or via outbreaks in poultry). This increased opportunity for accidental spillover to new host species increases the chances for the avian virus to adapt to mammals, including humans.
Likewise, there have also been an increased number of human cases of swine influenza reported by several European countries. A pro-active surveillance aiming at also detecting asymptomatic infections would allow an early detection of transmission that could help to prevent a new pandemic.
As a piloting approach during this specific project, some dedicated sentinel networks among at-risk workers will be initiated: people in poultry farms involved with the management of outbreaks of highly pathogenic avian influenza; people working at bird (or more generally wild life) rehabilitation centres or poultry farms; veterinarians working in pig farms/slaughterhouses.
Conditions
- Influenza, Human
Interventions
- DIAGNOSTIC_TEST
-
respiratory specimen
participants will perform self-sampling with a nasopharyngeal swab
- DIAGNOSTIC_TEST
-
serum
participants will be invited to get a blood sample taken by a general practitioner or to perform a self sampling of capillary blood
Sponsors & Collaborators
-
Sciensano
collaborator OTHER_GOV -
Belgian Federal Public Service, Food Chain Safety and Environment
collaborator OTHER_GOV -
Agentschap Zorg en Gezondheid
collaborator UNKNOWN -
Cyril Barbezange
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
Countries
- Belgium
Study Locations
More Related Trials
-
Studies of Avian Influenza Transmission to Humans in Egypt
NCT01150552 ·Status: COMPLETED
-
A Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness
NCT06779981 ·Status: COMPLETED
-
Prospective Study of AI H5N1 in China
NCT00428493 ·Status: COMPLETED
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
Avian Influenza Studies In Lebanon
NCT01107262 ·Status: COMPLETED
-
A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.
NCT05184387 ·Status: COMPLETED
-
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England
NCT03278067 ·Status: COMPLETED
-
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
NCT00711295 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity Study of the Influenza Vaccine in Adults
NCT00258934 ·Status: COMPLETED ·Phase: PHASE2
-
Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)
NCT02567721 ·Status: COMPLETED
-
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
NCT05027932 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
NCT00968526 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza
NCT01769430 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy Adults
NCT00457509 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care Workers
NCT01481467 ·Status: UNKNOWN ·Phase: NA
-
Feasibility of Cocooning Immunization Strategy With Influenza Vaccine
NCT00570037 ·Status: COMPLETED ·Phase: NA
-
B-cell Immunity to Influenza (SLVP017)- Year 5, 2013
NCT03020537 ·Status: COMPLETED ·Phase: PHASE4
-
China Case Control Avian Influenza
NCT00428753 ·Status: COMPLETED
-
Evaluating Modes of Influenza Transmission Between Humans
NCT01150149 ·Status: WITHDRAWN ·Phase: NA
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
NCT00329927 ·Status: COMPLETED ·Phase: PHASE2
-
Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in Europe
NCT00479921 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
NCT00537524 ·Status: COMPLETED ·Phase: PHASE2
-
Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs
NCT02124096 ·Status: COMPLETED
-
Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting
NCT02478905 ·Status: COMPLETED